Strategic Advocates’s Albemarle ALB Stock Holding History

Strategic Advocates’s Portfolio ALB Stock Details ALB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$53.9K	Sell	300 -5	-2%	-$854	0.24%	75
2025 Q4	$43.4K	Hold	305	–	–	0.01%	212
2025 Q3	$24.7K	Buy	+305	New	+$23.5K	0.01%	261

Other funds holding ALB

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Strategic Advocates's ALB Position: Q1 2026 in Review

Strategic Advocates reduced its Albemarle (ALB) stake by 1.6% in Q1 2026, selling an estimated $854 and leaving 300 shares worth $53.9K. The position accounts for 0.24% of the portfolio, ranked #75.

Strategic Advocates first reported a position in ALB in Q3 2025 and has held it in 3 quarters since. 982 funds tracked by Wall St. Rank hold ALB as of Q1 2026.

Strategic Advocates held 300 shares of Albemarle worth $53.9K as of Q1 2026.
Strategic Advocates sold 5 Albemarle shares in Q1 2026, an estimated $854.
Albemarle made up 0.24% of Strategic Advocates's portfolio in Q1 2026, its #75 holding.
Strategic Advocates first reported a position in Albemarle in Q3 2025 and has held it in 3 quarters since.
982 funds tracked by Wall St. Rank held Albemarle as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.